Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells

被引：0
|
作者：
Weidong Li
Xuesong Dong
Changjun He
Gang Tan
Ziyi Li
Bo Zhai
Jing Feng
Xian Jiang
Chang Liu
Hongchi Jiang
Xueying Sun
机构：
[1] The First Affiliated Hospital of Harbin Medical University,The Hepatosplenic Surgery Center
[2] The Fourth Affiliated Hospital of Harbin Medical University,Department of General Surgery
[3] The Third Affiliated Hospital of Harbin Medical University,Department of Surgery
来源：
Journal of Experimental & Clinical Cancer Research | / 40卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] FNDC5 Causes Resistance to Sorafenib by Activating the PI3K/Akt/Nrf2 Pathway in Hepatocellular Carcinoma Cells
    Liu, Huayuan
    Zhao, Lei
    Wang, Mengya
    Yang, Kexin
    Jin, Zhipeng
    Zhao, Chengjian
    Shi, Guangjun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] LncRNA HOTAIR contributes Taxol-resistance of hepatocellular carcinoma cells via activating AKT phosphorylation by down-regulating miR-34a (vol 40, BSR20201627, 2020)
    Duan, Yunfei
    BIOSCIENCE REPORTS, 2020, 41 (08)
  • [23] Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathway
    Xiang, Qing-Feng
    Zhan, Mei-Xiao
    Li, Yong
    Liang, Hui
    Hu, Cong
    Huang, Yao-Ming
    Xiao, Jing
    He, Xu
    Xin, Yong-Jie
    Chen, Min-Shan
    Lu, Li-Gong
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 83 - 89
  • [24] miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1
    Tan, Wenliang
    Lin, Zhirong
    Chen, Xianqing
    Li, Wenxin
    Zhu, Sicong
    Wei, Yingcheng
    Huo, Liyun
    Chen, Yajin
    Shang, Changzhen
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (01)
  • [25] Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth
    Liang-qi Cao
    Xue-wei Yang
    Yu-bin Chen
    Da-wei Zhang
    Xiao-Feng Jiang
    Ping Xue
    Molecular Cancer, 18
  • [26] Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth
    Cao, Liang-qi
    Yang, Xue-wei
    Chen, Yu-bin
    Zhang, Da-wei
    Jiang, Xiao-Feng
    Xue, Ping
    MOLECULAR CANCER, 2019, 18 (01)
  • [27] Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
    Chen, Kuen-Feng
    Chen, Hui-Ling
    Tai, Wei-Tien
    Feng, Wen-Chi
    Hsu, Chih-Hung
    Chen, Pei-Jer
    Cheng, Ann-Lii
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 337 (01): : 155 - 161
  • [28] Activation of PI3K/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells
    Chen, Kuen-Feng
    Feng, Wen-Chi
    Hsu, Chih-Hung
    Chen, Pei-Jer
    Cheng, Ann-Lii
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [29] Long noncoding RNA SNHG 16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5p
    Ye, Junfeng
    Zhang, Ruoyan
    Du, Xiaohong
    Chai, Wengang
    Zhou, Qiang
    ONCOTARGETS AND THERAPY, 2019, 12 : 415 - 422
  • [30] Upregulated lncRNA SNHG1 contributes to progression of nonsmall cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway
    Cui, Yun
    Zhang, Fuming
    Zhu, Chunkai
    Geng, Liang
    Tian, Tongde
    Liu, Huaimin
    ONCOTARGET, 2017, 8 (11) : 17785 - 17794
12345